Preclinical Demonstration of a Novel Treatment with High Efficacy and No Detectable Toxicity for Inflammatory Skin Conditions including Psoriasis

<div>H&amp;E stained PSE cells treated for 6 days with 3 mM allopurinol (a), 3 mM allopurinol plus 3 mM GSH (b), epidermal layer vitamin D (c), or dermal layer vitamin D (d). All slides were photographed with the same magnification (100x). (c) and (d) show markedly increased cell debris after vitamin D treatment.</div>

BioMed Research International

fig4

Figure 4

Figure 4: Preclinical Demonstration of a Novel Treatment with High Efficacy and No Detectable Toxicity for Inflammatory Skin Conditions including Psoriasis 

Figure 4 | Preclinical Demonstration of a Novel Treatment with High Efficacy and No Detectable Toxicity for Inflammatory Skin Conditions including Psoriasis 